+
Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review Article
  • Published:

Prostate cancer radiation and urethral strictures: a systematic review and meta-analysis

Prostate Cancer and Prostatic Diseases volume 21, pages 168–174 (2018)Cite this article

Subjects

Abstract

Background

We performed a systematic review and meta-analysis to determine the prevalence and predictors of urethral stricture development post radiation therapy (RT) for prostate cancer (PCa).

Methods

Published articles in PubMed/Medline, Cochrane, and Embase databases from January 2000 to April 2016 were queried. Inclusion criteria were any study that reported the prevalence of urethral strictures following external beam radiation therapy (EBRT), brachytherapy (BT), or both as a primary treatment for PCa. Forty-six articles met our inclusion criteria. A summary estimate of the proportion of patients who developed a urethral stricture was derived via a random effects meta-analysis.

Results

In total, 16,129 PCa patients underwent either EBRT (5681, 35.2%), BT (5849, 36.3%), or both (4599, 28.5%). Overall, 630 strictures were diagnosed at follow-up with a pooled estimate period prevalence of 2.2% (95% confidence interval, CI 1.9–2.6%) in a median follow-up time of 4 years (interquartile range, IQR 2.7–5). Of which, the pooled estimate prevalence was 1.5% (95% CI 0.9–2%) post EBRT, 1.9% (95% CI 1.3–2.4%) post BT, and 4.9% (95% CI 3.8–6%) post both EBRT and BT. Of 20 studies reporting a median time to stricture formation, the overall median time was 2.2 years (IQR 1.8–2.5, range 1.4–9). In a meta-regression analysis, receiving both EBRT and BT increased the estimated difference in proportion of stricture diagnoses by 3% (95% CI 1–6%), p = 0.018 compared to EBRT alone. An increase in median follow-up time was found to significantly increase the risk of developing urethral strictures (p = 0.04).

Conclusions

With a short-term follow-up, urethral strictures occur in 2.2% of men with PCa receiving radiotherapy. Receiving both EBRT and BT increased the risk of stricture formation. Longer follow-up is needed to determine the long-term natural history of stricture formation after RT.

Access through your institution
Buy or subscribe

This is a preview of subscription content, access via your institution

Access options

Access through your institution

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1

Similar content being viewed by others

References

  1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359–E86.

    Article  CAS  Google Scholar 

  2. Cooperberg MR, Broering JM, Carroll PR. Time trends and local variation in primary treatment of localized prostate cancer. J Clin Oncol. 2010;28:1117–23.

    Article  Google Scholar 

  3. Blackwell RH, Kandabarow AM, Gupta GN, Harkenrider MM, Quek ML, Flanigan RC. Long-term incidence of hematuria, urethral stricture and bladder cancer after radiation therapy for prostate cancer. Urol Pract. 2015;2:349–58.

    Article  Google Scholar 

  4. Tibbs MK. Wound healing following radiation therapy: a review. Radiother Oncol. 1997;42:99–106.

    Article  CAS  Google Scholar 

  5. Hofer MD, Zhao LC, Morey AF, Scott JF, Chang AJ, Brandes SB, et al. Outcomes after urethroplasty for radiotherapy induced bulbomembranous urethral stricture disease. J Urol. 2014;191:1307–12.

    Article  Google Scholar 

  6. Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4:1.

    Article  Google Scholar 

  7. Stock RG, Stone NN, Cesaretti JA, Rosenstein BS. Biologically effective dose values for prostate brachytherapy: effects on PSA failure and posttreatment biopsy results. Int J Radiat Oncol Biol Phys. 2006;64:527–33.

    Article  Google Scholar 

  8. Wells G, Shea B, O’connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa: Ottawa Hospital Research Institute; 2011.

  9. Hunter JP, Saratzis A, Sutton AJ, Boucher RH, Sayers RD, Bown MJ. In meta-analyses of proportion studies, funnel plots were found to be an inaccurate method of assessing publication bias. J Clin Epidemiol. 2014;67:897–903.

    Article  Google Scholar 

  10. Elliott SP, Meng MV, Elkin EP, McAninch JW, Duchane J, Carroll PR, et al. Incidence of urethral stricture after primary treatment for prostate cancer: data from CaPSURE. J Urol. 2007;178:529–34.

    Article  Google Scholar 

  11. Jarosek SL, Virnig BA, Chu H, Elliott SP. Propensity-weighted long-term risk of urinary adverse events after prostate cancer surgery, radiation, or both. Eur Urol. 2015;67:273–80.

    Article  Google Scholar 

  12. Rodda S, Tyldesley S, Morris WJ, Keyes M, Halperin R, Pai H, et al. ASCENDE-RT: an analysis of treatment-related morbidity for a randomized trial comparing a low-dose-rate brachytherapy boost with a dose-escalated external beam boost for high-and intermediate-risk prostate cancer. Int J Radiat Oncol Biol Phys. 2017;98:286–95.

    Article  Google Scholar 

  13. Mohammed N, Kestin L, Ghilezan M, Krauss D, Vicini F, Brabbins D, et al. Comparison of acute and late toxicities for three modern high-dose radiation treatment techniques for localized prostate cancer. Int J Radiat Oncol Biol Phys. 2012;82:204–12.

    Article  Google Scholar 

  14. Earley JJ, Abdelbaky AM, Cunningham MJ, Chadwick E, Langley SE, Laing RW. Correlation between prostate brachytherapy-related urethral stricture and peri-apical urethral dosimetry: A matched case–control study. Radiother Oncol. 2012;104:187–91.

    Article  Google Scholar 

  15. Seppenwoolde Y, Kolkman-Deurloo I-K, Sipkema D, de Langen M, Praag J, Jansen P, et al. HDR prostate monotherapy–dosimetric effects of implant deformation due to posture change between TRUS-and CT-imaging. Radiother Oncol. 2008;86:114–9.

    Article  Google Scholar 

  16. Morton G. The emerging role of high-dose-rate brachytherapy for prostate cancer. Clin Oncol. 2005;17:219–27.

    Article  CAS  Google Scholar 

  17. Myers MA, Hagan MP, Todor D, Gilbert L, Mukhopadhyay N, Randolf J, et al. Phase I/II trial of single-fraction high-dose-rate brachytherapy–boosted hypofractionated intensity-modulated radiation therapy for localized adenocarcinoma of the prostate. Brachytherapy. 2012;11:292–8.

    Article  Google Scholar 

  18. Spratt DE, Soni PD, McLaughlin PW, Merrick GS, Stock RG, Blasko JC, et al. American Brachytherapy Society Task Group Report: combination of brachytherapy and external beam radiation for high-risk prostate cancer. Brachytherapy. 2017;16:1–12.

    Article  Google Scholar 

  19. Sweeney C, Xie W, Regan MM, Nakabayashi M, Buyse ME, Clarke NW, et al. Disease-free survival (DFS) as a surrogate for overall survival (OS) in localized prostate cancer (CaP). American Society of Clinical Oncology; 2016;5023.

  20. Allen ZA, Merrick GS, Butler WM, Wallner KE, Kurko B, Anderson RL, et al. Detailed urethral dosimetry in the evaluation of prostate brachytherapy-related urinary morbidity. Int J Radiat Oncol Biol Phys. 2005;62:981–7.

    Article  Google Scholar 

  21. Merrick GS, Butler WM, Wallner KE, Galbreath RW, Lief JH. Long-term urinary quality of life after permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2003;56:454–61.

    Article  Google Scholar 

  22. Butler WM, Merrick GS, Dorsey AT, Hagedorn BM. Comparison of dose length, area, and volume histograms as quantifiers of urethral dose in prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2000;48:1575–82.

    Article  CAS  Google Scholar 

  23. Sullivan L, Williams SG, Tai KH, Foroudi F, Cleeve L, Duchesne GM. Urethral stricture following high dose rate brachytherapy for prostate cancer. Radiother Oncol. 2009;91:232–6.

    Article  Google Scholar 

  24. Bece A, Patanjali N, Jackson M, Whitaker M, Hruby G. High-dose-rate brachytherapy boost for prostate cancer: outcomes and genitourinary toxicity. Brachytherapy. 2015;14:670–6.

    Article  Google Scholar 

  25. Kaprealian T, Weinberg V, Speight JL, Gottschalk AR, Roach M, Shinohara K, et al. High-dose-rate brachytherapy boost for prostate cancer: comparison of two different fractionation schemes. Int J Radiat Oncol Biol Phys. 2012;82:222–7.

    Article  Google Scholar 

  26. Walsh PC, RA, Vaughan ED, Wein AJ, eds.. Campbell’s urology. 7th ed. Philadelphia: WB Saunders; 1998.

    Google Scholar 

  27. Madersbacher S, Marberger M. Is transurethral resection of the prostate still justified. BJU Int. 1999;83:227–37.

    Article  CAS  Google Scholar 

  28. Seymore CH, El-Mahdi AM, Schellhammer PF. The effect of prior transurethral resection of the prostate on post radiation urethral strictures and bladder neck contractures. Int J Radiat Oncol Biol Phys. 1986;12:1597–600.

    Article  CAS  Google Scholar 

  29. Ishiyama H, Satoh T, Kitano M, Tabata K-I, Komori S, Ikeda M, et al. High-dose-rate brachytherapy and hypofractionated external beam radiotherapy combined with long-term hormonal therapy for high-risk and very high-risk prostate cancer: outcomes after 5-year follow-up. J Radiat Res. 2013;55:509–17.

    Article  Google Scholar 

  30. Merrick GS, Butler WM, Tollenaar BG, Galbreath RW, Lief JH. The dosimetry of prostate brachytherapy-induced urethral strictures. Int J Radiat Oncol Biol Phys. 2002;52:461–8.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, University of California—San Francisco, San Francisco, CA, USA

    Mohannad A. Awad, Thomas W. Gaither, Gregory P. Murphy, Nima Baradaran & Benjamin N. Breyer

  2. Department of Surgery, King Abdulaziz University, Rabigh, Saudi Arabia

    Mohannad A. Awad

  3. Department of Surgery, University of Texas—Dell Medical School, Austin, TX, USA

    E. Charles Osterberg

  4. Department of Biostatistics and Epidemiology, University of California—San Francisco, San Francisco, CA, USA

    Benjamin N. Breyer

Authors
  1. Mohannad A. Awad
    View author publications

    You can also search for this author inPubMed Google Scholar

  2. Thomas W. Gaither
    View author publications

    You can also search for this author inPubMed Google Scholar

  3. E. Charles Osterberg
    View author publications

    You can also search for this author inPubMed Google Scholar

  4. Gregory P. Murphy
    View author publications

    You can also search for this author inPubMed Google Scholar

  5. Nima Baradaran
    View author publications

    You can also search for this author inPubMed Google Scholar

  6. Benjamin N. Breyer
    View author publications

    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence to Mohannad A. Awad.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Electronic supplementary material

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Awad, M.A., Gaither, T.W., Osterberg, E.C. et al. Prostate cancer radiation and urethral strictures: a systematic review and meta-analysis. Prostate Cancer Prostatic Dis 21, 168–174 (2018). https://doi.org/10.1038/s41391-017-0028-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41391-017-0028-3

This article is cited by

Search

Advanced search

Quick links

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载